Hyperion Therapeutics
AcquiredSouth San Francisco, United States · Founded 2006 · $117.5M raised
- Headquarters
- South San Francisco, California
- Employees
- 51–200
- Founded
- 2006
- Business Model
- B2B
- Total Funding
- $117.5M
- Last Round
- $17.5M Venture RoundApr 2011
- Rounds
- 4
- Acquired by
- Horizon PharmaMay 2015 · $1.1B
About
Hyperion Therapeutics was a Brisbane, CA-based commercial-stage biopharmaceutical company founded in 2006, focused on orphan diseases. The company developed and commercialized RAVICTI (glycerol phenylbutyrate) and BUPHENYL for urea cycle disorders. Hyperion went public on Nasdaq before being acquired by Horizon Pharma in May 2015 for approximately $1.1 billion.
Summary
Hyperion Therapeutics is a Biotech company based in South San Francisco, United States, founded in 2006. It has raised $117.5M in total across 4 rounds, most recently a $17.5M Venture Round round in Apr 2011.
Funding History
May 2015
Sign up to see all 5 rounds
Series A through Acquisition — per-round amounts, valuations, and who invested in each round.
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/hyperion-therapeutics"><img src="https://indexed.vc/api/badge/company/hyperion-therapeutics" alt="Hyperion Therapeutics on Indexed.vc" width="260" height="76" /></a>